Vaisala Group
Vaisala Corporation: Share Repurchase 12.8.2025
Vaisala Corporation: Share Repurchase 12.8.2025
| VAISALA CORPORATION | STOCK EXCHANGE RELEASE 12.8.2025 | |
| Vaisala Corporation: Share Repurchase 12.8.2025 | ||
| In the Helsinki Stock Exchange | ||
| Trade date | 12.8.2025 | |
| Bourse trade | Buy | |
| Share | VAIAS | |
| Amount | 900 | Shares |
| Average price/ share | 46,9312 | EUR |
| Total cost | 42 238,08 | EUR |
| Vaisala Corporation now holds a total of 136 726 shares | ||
| including the shares repurchased on 12.8.2025 | ||
| The share buybacks are executed in compliance with Regulation | ||
| No. 596/2014 of the European Parliament and Council (MAR) Article 5 | ||
| and the Commission Delegated Regulation (EU) 2016/1052. | ||
| On behalf of Vaisala Corporation | ||
| Nordea Bank Oyj | ||
| Sami Huttunen | Ilari Isomäki | |
More information:
Niina Ala-Luopa
+358 400 728 957, ir@vaisala.com
Distribution:
Nasdaq Helsinki
Key media
vaisala.com
Vaisala is a global leader in measurement instruments and intelligence for climate action. We equip our customers with devices and data to improve resource efficiency, drive energy transition, and care for the safety and well-being of people and societies worldwide. With almost 90 years of innovation and expertise, we employ a team of close to 2,500 experts committed to taking every measure for the planet. Vaisala series A shares are listed on the Nasdaq Helsinki stock exchange. www.vaisala.com
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S12.8.2025 20:36:02 CEST | Press release
Capital Increase in Genmab as a Result of Employee Warrant Exercise
ThreatLocker Inc12.8.2025 20:05:14 CEST | Press release
ThreatLocker Chosen for 2025 Inc. 5000 List of America's Fastest-Growing Private Companies
Idorsia Pharmaceuticals Ltd12.8.2025 19:00:00 CEST | Press release
TRYVIO nominated for the 2025 Prix Galien USA “Best Pharmaceutical Product”
TOUAX12.8.2025 17:45:00 CEST | Press release
Touax: Effective transfer of TOUAX SCA shares to Euronext Growth® Paris and delisting from the regulated market of Euronext Paris
Aspo Plc12.8.2025 16:30:00 CEST | Press release
Aspo to publish its Half-year Financial Report for January-June 2025 on Monday, August 18, 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom